Markets 
About 1.4 million medical devices are registered with the Therapeutic Goods Administration. These devices are critical in maintaining a person’s health, and indeed can be instrumental in saving a life. At the same time, more than 150,000 incidents with devices require hospital treatment each year, according to the Australian Institute of Health and Welfare.
That offers only a partial insight into the scale of any issues, and getting a better picture is infuriatingly difficult. The TGA, the medical devices watchdog, will not say how many reports it receives of injuries or deaths linked to devices each year.
It took the Medical Malfunctions investigative series from this masthead and 60 Minutes to dig out data using digital scrapers and unearth more than 80,000 logs of medical device side-effects, recalls and hazard alerts. What that showed is that the number of deaths, injuries and adverse-event reports is rising. Since 2020, the number of deaths involving medical devices stands at 679, while injuries total 30,377.
Trying to figure out which devices were involved in the most incidents would have been impossible without the endeavour of journalist Liam Mannix.
The effort it took to unearth this information from an ostensibly public database shows that the TGA website is completely unfit for purpose. The TGA requires event reporting and then “publishes” those reports, but both of these acts are then sabotaged by the database’s diabolical design.
Even the TGA does not have a decent handle on its own data. The investigation discovered many deaths before October 2019 were not logged. After this masthead questioned the TGA, a warning was published on its website of a “technical issue” with the database.
The investigation has revealed other systemic deficiencies. In the past decade, more than 55,000 devices have been approved for use in Australia and 830 have been rejected. About 85 per cent of those devices are approved through their European certification, some of which is awarded by for-profit notified companies in Germany which receive fees from the makers of devices they certify.
This does not mean the certification is incorrect, but to rely on such a narrow and commercially motivated pipeline throws doubt over the independence of the process.
As Associate Professor Marco Rizzi, an expert in therapeutic goods at the University of Western Australia, says: “If you have the CE mark [European approval], it gives you an automatic way in without independent oversight.”
As TGA insiders have told us, defects in the system of approving and monitoring medical devices flooding this country are making a nonsense of the TGA’s stated aim of regulating therapeutic goods for “safety, efficacy, performance and quality to help protect and improve the health of Australians”.
Last November, during an online staff briefing, TGA employees expressed doubts about the regulator’s role and efficacy. One said: “We are biased by serving industry rather than the general public, our most important stakeholder.”
This goes to the heart of what should define a regulatory regime. The only stakeholder whose life depends on the regime is the patient.
Such is the extent of the TGA’s approvals of devices that a true evaluation and audit of each device is impossible – hence the reliance on European certification.
“There are too many devices to deal with,” said a former TGA medical devices auditor. This, however, is a dangerous path, as another TGA insider conceded: “It’s a race to the bottom. You can shop around for the one that will get you through.”
As our case studies have shown, the consequence of a faulty medical device can change or threaten a person’s life. The TGA owes it to the public to provide freely accessible data so that informed decisions can be made within a trustworthy system. This is not the world we live in.
Start the day with a summary of the day’s most important and interesting stories, analysis and insights. Sign up for our Morning Edition newsletter.
The Herald’s View – Since the Herald was first published in 1831, the editorial team has believed it important to express a considered view on the issues of the day for readers, always putting the public interest first.From our partners
Read the full article here
